CaSR / TRP channels
Name: Extracellular calcium-sensing receptor
(CaSR)
Official Symbol: CASR
provided by HGNC
Function:
Senses changes in the extracellular concentration of calcium ions. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system.
Source: Reorganizing the protein space at the Universal Protein Resource (UniProt)
Nucleic Acids Res. 40: D71-D75 (2012).
Species | External DB | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Entrez Gene | UniprotKB | DIP | IntAct | MINT | BioGRID | STRING | IUPHAR-DB | KEGG | OMIM | |
Human
|
846 | P41180 | DIP-5975N | P41180 | 107296 | P41180 | hsa:846 | 601199 | ||
Mouse
|
12374 | Q9QY96 | 198504 | Q9QY96 | mmu:12374 | |||||
Rat
|
24247 | P48442 | P48442 | 246432 | P48442 | rno:24247 |
PPI pairs:
Biological Process:
- GO:0009653 : anatomical structure morphogenesis
- GO:0070509 : calcium ion import
- GO:0006874 : cellular calcium ion homeostasis
- GO:0007635 : chemosensory behavior
- GO:0005513 : detection of calcium ion
- GO:0001503 : ossification
Source: The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet.. May 2000;25(1):25-9.
World Wide Web URL: http://www.geneontology.org/
World Wide Web URL: http://www.geneontology.org/
Disease:
- OMIM:601199 : Hypocalciuric hypercalcemia, type I (OMIM:145980 )
- OMIM:601199 : Hyperparathyroidism, neonatal (OMIM:239200 )
- OMIM:601199 : Hypocalcemia, autosomal dominant (OMIM:146200 )
- OMIM:601199 : Hypocalcemia, autosomal dominant, with Bartter syndrome (OMIM: )
- OMIM:601199 : Epilepsy, idiopathic generalized, susceptibility to, 8 (OMIM:612899 )
Source: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University (Baltimore, MD), May, 2012.
World Wide Web URL: http://omim.org/
World Wide Web URL: http://omim.org/
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Screening | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Experimental screening | Non-experimental screening | Reference | ||||||||
TRP channel construct | Interactor source | |||||||||
TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
TRPC3 | CaSR | Inference | Prediction | 22778254 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Validation: In vivo validation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
TRPC3 | CaSR | Co-immunofluorescence staining | Mouse submandibular gland (SMG) ductal tissue section | 22778254 | ||||||
TRPC3 | CaSR | Co-immunoprecipitation | Mouse submandibular gland (SMG) ductal cell lysates | 22778254 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening Validation: In vitro validation Validation: In vivo validation Characterization Functional consequence | top |
Functional consequence | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
TRP channel | Interactor | Method | Post-translational modification | Subcellular trafficking | Activity | Reference | ||||||
TRPC3 | CaSR | Cell surface biotinylation | Increase in plasma membrane level | 22778254 |
(:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)